{"id":"https://openalex.org/W156240486","doi":null,"title":"Targeting the IL-1 family members in skin inflammation.","display_name":"Targeting the IL-1 family members in skin inflammation.","publication_year":2010,"publication_date":"2010-11-01","ids":{"openalex":"https://openalex.org/W156240486","mag":"156240486","pmid":"https://pubmed.ncbi.nlm.nih.gov/21157640","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3059231"},"language":"en","primary_location":{"id":"pmid:21157640","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21157640","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3059231/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5014073749","display_name":"Liselotte E. Jensen","orcid":"https://orcid.org/0000-0002-0267-8312","observed_orcids":["https://orcid.org/0000-0002-0267-8312"]},"institutions":[{"id":"https://openalex.org/I84392919","display_name":"Temple University","ror":"https://ror.org/00kx1jb78","country_code":"US","type":"education","lineage":["https://openalex.org/I84392919"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Liselotte E Jensen","raw_affiliation_strings":["Temple University School of Medicine, Department of Microbiology and Immunology, 1158 MERB, 3500 North Broad Street, Philadelphia, PA 19140-4106, USA. liselott@temple.edu"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Temple University School of Medicine, Department of Microbiology and Immunology, 1158 MERB, 3500 North Broad Street, Philadelphia, PA 19140-4106, USA. liselott@temple.edu","institution_ids":["https://openalex.org/I84392919"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5014073749"],"corresponding_institution_ids":["https://openalex.org/I84392919"],"apc_list":null,"apc_paid":null,"fwci":1.2852,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.77174703,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"11","issue":"11","first_page":"1211","last_page":"20"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.4140999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.4140999913215637,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.24150000512599945,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.21529999375343323,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-1-cytokine-family","display_name":"IL-1 family cytokines","score":0.8870000243186951},{"id":"https://openalex.org/keywords/skin-inflammation","display_name":"skin inflammation","score":0.921999990940094},{"id":"https://openalex.org/keywords/il-1-receptor","display_name":"IL-1 receptor","score":0.9010000228881836},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.9150000214576721},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":1.0},{"id":"https://openalex.org/keywords/contact-dermatitis","display_name":"contact dermatitis","score":1.0},{"id":"https://openalex.org/keywords/cutaneous-lupus-erythematosus","display_name":"cutaneous lupus erythematosus","score":1.0},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.5519999861717224},{"id":"https://openalex.org/keywords/il-1-inhibition","display_name":"IL-1 inhibition","score":0.8180000185966492}],"concepts":[{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.8301632404327393},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7777533531188965},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6213728785514832},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5962974429130554},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5899341702461243},{"id":"https://openalex.org/C133925201","wikidata":"https://www.wikidata.org/wiki/Q188419","display_name":"Life expectancy","level":3,"score":0.45680564641952515},{"id":"https://openalex.org/C2777524370","wikidata":"https://www.wikidata.org/wiki/Q5075435","display_name":"Alopecia areata","level":2,"score":0.44316571950912476},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.34940677881240845},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":3,"locations":[{"id":"pmid:21157640","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21157640","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current opinion in investigational drugs (London, England : 2000)","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3059231","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3059231/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Curr Opin Investig Drugs","raw_type":"Text"},{"id":"mag:156240486","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21157640","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3059231","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3059231/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Curr Opin Investig Drugs","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[{"id":"https://openalex.org/G771731791","display_name":"Soluble IL-1RAcP proteins as inhibitors of inflammation","funder_award_id":"R03AR053672","funder_id":"https://openalex.org/F4320337362","funder_display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases"}],"funders":[{"id":"https://openalex.org/F4320337362","display_name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","ror":"https://ror.org/006zn3t30"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":80,"referenced_works":["https://openalex.org/W1483716260","https://openalex.org/W1542185599","https://openalex.org/W1549464896","https://openalex.org/W1589480349","https://openalex.org/W1591918677","https://openalex.org/W1593615257","https://openalex.org/W1637051416","https://openalex.org/W1903523261","https://openalex.org/W1927991005","https://openalex.org/W1965170225","https://openalex.org/W1965398568","https://openalex.org/W1965440416","https://openalex.org/W1968955229","https://openalex.org/W1970738791","https://openalex.org/W1972246503","https://openalex.org/W1977085315","https://openalex.org/W1981398391","https://openalex.org/W1986696886","https://openalex.org/W1987112020","https://openalex.org/W1987582894","https://openalex.org/W1989355936","https://openalex.org/W1998081672","https://openalex.org/W1999807078","https://openalex.org/W2002535758","https://openalex.org/W2002892444","https://openalex.org/W2004937659","https://openalex.org/W2008186427","https://openalex.org/W2013068598","https://openalex.org/W2014171507","https://openalex.org/W2018387958","https://openalex.org/W2020706532","https://openalex.org/W2028832882","https://openalex.org/W2031745594","https://openalex.org/W2032342879","https://openalex.org/W2036659843","https://openalex.org/W2039722030","https://openalex.org/W2047868805","https://openalex.org/W2051771323","https://openalex.org/W2054985203","https://openalex.org/W2056943627","https://openalex.org/W2065805648","https://openalex.org/W2065937204","https://openalex.org/W2069526125","https://openalex.org/W2069935301","https://openalex.org/W2072794124","https://openalex.org/W2073258495","https://openalex.org/W2074163446","https://openalex.org/W2078489088","https://openalex.org/W2079778462","https://openalex.org/W2082814058","https://openalex.org/W2093396768","https://openalex.org/W2103533676","https://openalex.org/W2104152486","https://openalex.org/W2110816580","https://openalex.org/W2112417497","https://openalex.org/W2114395339","https://openalex.org/W2114830069","https://openalex.org/W2115234798","https://openalex.org/W2115754452","https://openalex.org/W2115807849","https://openalex.org/W2119255196","https://openalex.org/W2121369239","https://openalex.org/W2128218039","https://openalex.org/W2129931628","https://openalex.org/W2131998339","https://openalex.org/W2135491202","https://openalex.org/W2135791851","https://openalex.org/W2141380223","https://openalex.org/W2152486718","https://openalex.org/W2154709330","https://openalex.org/W2156089995","https://openalex.org/W2157710399","https://openalex.org/W2159587574","https://openalex.org/W2165275387","https://openalex.org/W2166611766","https://openalex.org/W2169264831","https://openalex.org/W2169362733","https://openalex.org/W2413887259","https://openalex.org/W2414379895","https://openalex.org/W2471421056"],"related_works":["https://openalex.org/W3137214859","https://openalex.org/W4205190216","https://openalex.org/W4292686500","https://openalex.org/W2031745594","https://openalex.org/W2408123484","https://openalex.org/W2099578672","https://openalex.org/W2342894847","https://openalex.org/W30046310","https://openalex.org/W4200169016","https://openalex.org/W3127583700"],"abstract_inverted_index":{"The":[0],"IL-1":[1,28,83,96],"family":[2,84,97],"of":[3,21,26,52,94],"cytokines":[4],"comprises":[5],"11":[6],"proteins":[7],"with":[8],"pro-":[9],"and":[10,23,41,54,57],"anti-inflammatory":[11],"functions":[12],"that":[13],"are":[14,60,68],"mediated":[15],"through":[16],"an":[17],"equally":[18],"large":[19],"group":[20],"receptors":[22],"coreceptors.":[24],"Dysregulation":[25],"the":[27,78,91,95],"system":[29],"may":[30,99],"lead":[31],"to":[32],"diseases":[33,67],"such":[34],"as":[35],"psoriasis,":[36],"atopic":[37],"dermatitis,":[38],"contact":[39],"dermatitis":[40],"cutaneous":[42],"lupus":[43],"erythematosus.":[44],"These":[45],"inflammatory":[46],"skin":[47,87],"conditions":[48],"greatly":[49],"affect":[50],"quality":[51],"life":[53,55],"expectancy,":[56],"their":[58],"frequencies":[59],"increasing.":[61],"However,":[62],"treatment":[63],"options":[64],"for":[65],"these":[66],"unsatisfactory.":[69],"This":[70],"review":[71],"briefly":[72],"summarizes":[73],"new":[74],"findings,":[75],"reported":[76],"in":[77,86],"past":[79],"2":[80],"years,":[81],"implicating":[82],"members":[85,98],"inflammation.":[88],"Furthermore,":[89],"how":[90],"biological":[92],"activities":[93],"be":[100],"inhibited":[101],"is":[102],"discussed.":[103]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}